IPP Bureau
India Pharma 2026 showcases sectoral transformation through four key plenary discussions
By IPP Bureau - April 14, 2026
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
Briefs: Indoco Remedies and Panacea Biotec
By IPP Bureau - April 14, 2026
Panacea Biotec receives LoA from CMSS
FDA fast-tracks Daiichi Sankyo & Merck lung cancer drug review
By IPP Bureau - April 14, 2026
The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis
Eli Lilly posts strong Phase 3 win for Jaypirca combo in blood cancer trial
By IPP Bureau - April 14, 2026
Benefits were consistent across all key subgroups, including patients previously treated with covalent BTK inhibitors
NASA’s Artemis II mission to on board Opella’s Dulcolax for lunar orbit mission
By IPP Bureau - April 14, 2026
A brand from Opella will be part of the official NASA astronaut formulary
Roche wins CE mark for blood-based MS brain damage test
By IPP Bureau - April 14, 2026
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
Aster DM Healthcare invests Rs 96 crore to add 159-bed specialised Aster Women & Children centre in Bengaluru
By IPP Bureau - April 14, 2026
With the expansion, the hospital’s total bed capacity will rise from 380 to 539 beds
AbbVie Phase 2 data show 62% response rate in ovarian cancer combo trial
By IPP Bureau - April 14, 2026
Highlights Mirvetuximab-based regimen promise
Apollo Hospitals Navi Mumbai launches dedicated paediatric rehabilitation centre
By IPP Bureau - April 14, 2026
The centre offers a full spectrum of FDA-approved services, including physiotherapy, occupational therapy, speech and language therapy, and aqua therapy
Max Institute of Cancer Care, Vaishali showcases advanced oncology technologies at ONCO-CON 2026
By IPP Bureau - April 14, 2026
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
Sun Pharma unveils new brand film highlighting shared ‘No. 1’ spirit with Royal Challengers Bengaluru
By IPP Bureau - April 14, 2026
The campaign builds on the three-year partnership unveiled earlier this season
Happiest Health expands dental care footprint with its second Happiest Pearls Clinic
By IPP Bureau - April 14, 2026
Spread across nearly 4,500 sq. ft., the new clinic combines advanced dental technology, experienced specialists, and an Atithi-first care model
Shalby Hospitals gets 5-year kidney transplant approval for Ahmedabad Krishna Unit
By IPP Bureau - April 14, 2026
The license is valid for five years, effective from April 9, 2026
Pharma firms accelerate regional GLP-1 capacity to de-risk supply chains amid geopolitical tensions: GlobalData
By IPP Bureau - April 14, 2026
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
ICPA to host India Unlimited 4.0 in San Diego to spotlight India’s global biopharma role
By IPP Bureau - April 13, 2026
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
